文献速递生殖医学

超重或肥胖女性体重下降与生殖结局的关联:基于英国真实世界数据的队列研究

Association between weight loss and reproductive outcomes among women with overweight or obesity: a cohort study using UK real-world data.
PubMed 文献 · Hum Reprod · 2025-01-01

基于英国初级保健与医院记录链接的队列研究,纳入246 670例BMI≥25 kg/m2的18-40岁女性,比较体重下降10-25%与体重稳定者的妊娠几率及妊娠并发症。体重下降与妊娠几率增加相关(HR 1.05),并降低妊娠期糖尿病(OR 0.58)和急诊剖宫产(OR 0.82)风险,但研究不能推断因果。

要点

  • 体重下降10-25%与妊娠几率增加5.2%相关(HR 1.05,95%CI 1.02-1.09)。
  • 体重下降使妊娠期糖尿病风险降低42%(OR 0.58,95%CI 0.48-0.70)。
  • 体重下降使急诊剖宫产风险显著降低(OR 0.82,95%CI 0.71-0.95)。

核心结论

  • 在超重或肥胖女性中,体重下降与妊娠几率增加相关。
  • 体重下降与妊娠期糖尿病和急诊剖宫产风险降低相关,但不能推断因果。

研究设计与样本

  • 大型队列研究,数据来自2000年1月至2022年5月英格兰初级保健诊所链接医院记录。
  • 纳入18-40岁、BMI≥25 kg/m2的女性,数据提取自英国临床实践研究数据链Aurum电子病历数据库。
  • 最终队列246 670例,其中体重稳定组195 666例,体重下降组51 004例。
  • 主要结局为3年随访期间首次记录的妊娠。

主要发现

  • 妊娠发生于22 756/246 670(9.2%)女性。
  • 体重下降10-25%(中位数14%)与随后3年妊娠几率增加5.2%相关(HR 1.05;95%CI 1.02,1.09;P=0.003),对照为体重稳定。
  • 妊娠期糖尿病报告于950/11 825(8.0%)女性,体重下降使妊娠期糖尿病风险降低42%(OR 0.58;95%CI 0.48,0.70;P<0.001)。
  • 急诊剖宫产发生于1453/11 558(12.6%)妊娠,体重下降队列显著降低(OR 0.82;95%CI 0.71,0.95;P=0.008)。
  • 妊娠期高血压报告于244/11 740(2.1%)女性,大于胎龄儿发生于791/7988(9.9%)女性;体重下降与妊娠期高血压(OR 0.77;95%CI 0.55,1.07;P=0.121)和大于胎龄儿风险(OR 0.86;95%CI 0.72,1.04;P=0.117)的降低无统计学显著。

临床怎么用

  • 原文未据此给出推荐。
  • 作者指出,既往研究多关注接受生育治疗女性的结局,本研究未限于积极尝试妊娠者,体重下降的获益在积极尝试妊娠的女性中可能更大。
  • 作者指出,研究不能推断因果,因未知更高的妊娠率是否由体重下降引起。

局限性

  • 研究中妊娠意图未知,有妊娠意图的女性更可能尝试减重,纳入无妊娠意图女性可能低估体重下降与妊娠几率之间的真实关系。
  • 评估了18-40岁女性,但由于需要两次BMI记录,队列中位指数日期年龄为30岁,限制了研究结果的普遍性。
  • 虽然观察到体重下降与妊娠几率增加之间的关联,但不能推断因果,因未知更高的妊娠率是否由体重下降引起。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: In women with BMI ≥25 kg/m2, does a 10-25% weight loss versus stable weight increase the chance of pregnancy? SUMMARY ANSWER: In women with overweight or obesity, weight loss was associated with an increase in the chance of pregnancy. WHAT IS KNOWN ALREADY: Weight loss has been shown to improve conception rates among women with overweight or obesity and concomitant polycystic ovary syndrome (PCOS). However, evidence on the effect of weight loss on conception rates among the general population of women with overweight or obesity, irrespective of PCOS status, is lacking. STUDY DESIGN, SIZE, DURATION: A large cohort study of patient data collected from primary-care practices linked to hospital records in England between January 2000 and May 2022. PARTICIPANTS/MATERIALS, SETTING, METHODS: Women were included if they were aged 18-40 years with BMI ≥25 kg/m2. Patient data were extracted from the UK Clinical Practice Research Datalink Aurum database of electronic medical records. The primary outcome was the first pregnancy recorded during a 3-year follow-up period. Key secondary outcomes were the occurrence of miscarriage, gestational diabetes, and pregnancy-induced hypertension, as well as emergency caesarean section, and risk of babies being born large for gestational age (LGA). MAIN RESULTS AND THE ROLE OF CHANCE: The final cohort of 246 670 women comprised 195 666 who kept a stable weight and 51 004 who lost weight. Pregnancy occurred in 22 756/246 670 (9.2%) women. On average, a 10-25% weight loss (median 14%) was associated with a 5.2% increase in the chance of pregnancy over the following 3 years (hazard ratio 1.05; 95% CI 1.02, 1.09; P = 0.003) compared with stable weight. Gestational diabetes was reported for 950/11 825 (8.0%) women, and weight loss reduced the risk of gestational diabetes by 42% (odds ratio [OR] 0.58; 95% CI 0.48, 0.70; P < 0.001). Emergency caesarean section was performed in 1453/11 558 (12.6%) pregnancies. This intervention was significantly reduced in the weight-loss cohort (OR 0.82; 95% CI 0.71, 0.95; P = 0.008). Pregnancy-induced hypertension was reported in a few women (244/11 740 [2.1%]) and one-tenth of women (791/7988 [9.9%]) gave birth to babies who were LGA. Weight loss prior to pregnancy resulted in non-significant reductions in pregnancy-induced hypertension (OR 0.77; 95% CI 0.55, 1.07; P = 0.121) and risk of babies being born LGA (OR 0.86; 95% CI 0.72, 1.04; P = 0.117). Rates of miscarriages, preterm births, live births, or babies born small for gestational age were not impacted by weight loss. LIMITATIONS, REASONS FOR CAUTION: In our study, the intention of pregnancy was unknown. Women who intend to conceive are more likely to attempt weight loss. The inclusion of women who do not intend to conceive may therefore underestimate the true relationship between weight loss and chance of pregnancy. Also, we assessed women aged between 18 and 40 years, but due to the requirement of having two BMI records, the median age at index date across the cohort was 30 years which limits the generalizability of our findings. Furthermore, while an association between weight loss and increased chance of pregnancy was observed, we cannot imply causality as it is unknown whether higher pregnancy rates were caused by weight loss. WIDER IMPLICATIONS OF THE FINDINGS: These findings provide further evidence of the association of weight loss with reproductive outcomes in a broad population of women with overweight or obesity, including those with PCOS. Previous studies have focused mostly on outcomes in women undergoing fertility treatment. Our study was not restricted to those actively trying to conceive and, therefore, the benefit of weight loss may be even greater in women who are actively trying to become pregnant. STUDY FUNDING/COMPETING INTEREST(S): This study was funded by Novo Nordisk A/S. A.H.B. declares consultancy fees from Novo Nordisk A/S. M.L.V., V.S., E.W.L., and A.R.G. are employees of and/or hold shares in Novo Nordisk A/S. A.R.G. holds stock in Novo Nordisk. Medical writing support was provided by Carolyn Bowler, PhD, CMPP, of Apollo, OPEN Health Communications, and funded by Novo Nordisk A/S, in accordance with Good Publication Practice (GPP) guidelines (GPP 2022) (ismpp.org). TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Verfürden ML, Schnecke V, Winning Lehmann E, et al. Association between weight loss and reproductive outcomes among women with overweight or obesity: a cohort study using UK real-world data. Hum Reprod. 2025. PMID: 40618200. doi:10.1093/humrep/deaf122

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。